A recent study showed that OSA-modified starch effectively promoted satiety in mice, which was accompanied by increased plasma levels of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) [10]. The gene discussed is GCG; the disease is obstructive sleep apnea syndrome.